Cargando…

Betatrophin association with serum triglyceride levels in obstructive sleep apnea patients

BACKGROUND: Obstructive sleep apnea (OSA) is a common sleep problem, in which patients are at increased risk for metabolic and cardiovascular problems, including metabolic syndrome, diabetes mellitus (DM), and dyslipidemia. Betatrophin is a novel protein that regulates fatty acid and triglyceride (T...

Descripción completa

Detalles Bibliográficos
Autores principales: Sertogullarindan, Bunyamin, Komuroglu, Ahmet Ufuk, Ucler, Rifki, Gunbatar, Hulya, Sunnetcioglu, Aysel, Cokluk, Erdem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341867/
https://www.ncbi.nlm.nih.gov/pubmed/30745937
http://dx.doi.org/10.4103/atm.ATM_52_18
_version_ 1783389029628116992
author Sertogullarindan, Bunyamin
Komuroglu, Ahmet Ufuk
Ucler, Rifki
Gunbatar, Hulya
Sunnetcioglu, Aysel
Cokluk, Erdem
author_facet Sertogullarindan, Bunyamin
Komuroglu, Ahmet Ufuk
Ucler, Rifki
Gunbatar, Hulya
Sunnetcioglu, Aysel
Cokluk, Erdem
author_sort Sertogullarindan, Bunyamin
collection PubMed
description BACKGROUND: Obstructive sleep apnea (OSA) is a common sleep problem, in which patients are at increased risk for metabolic and cardiovascular problems, including metabolic syndrome, diabetes mellitus (DM), and dyslipidemia. Betatrophin is a novel protein that regulates fatty acid and triglyceride (TG) metabolism and is related to obesity and metabolic abnormalities, including metabolic syndrome, DM, and dyslipidemia. Although OSA and betatrophin share common abnormalities, their relationship has not been investigated. AIM: The aim of this study is to investigate the relationships among betatrophin, OSA, and the serum lipid profile. METHODS: Ninety consecutive patients with suspected OSA underwent polysomnography (PSG) to confirm OSA. Plasma betatrophin, leptin, adiponectin, and the full lipid profile were analyzed. The patients were categorized as OSA or control based on the apnea-hypopnea index (AHI). RESULTS: About 61% of patients had OSA, and 39% had normal PSG. The levels of betatrophin, leptin, and adiponectin were higher in patients with OSA (256.59 ± 29.35, 374.20 ± 37.93, and 17.86 ± 2.63 μg/mL, respectively) compared to the controls (141.86 ± 26.20, 205.53 ± 14.75, and 7.52 ± 1.02 μg/mL, respectively). Betatrophin levels were correlated with the AHI, leptin (r = 0.413, P = 0.002, r = 0.782, P = 0.000). TG levels were significantly higher, and high-density lipoprotein cholesterol (HDL-C) levels were lower, in OSA patients compared to controls (244 ± 20.33 vs. 138 ± 14.89, and 37.21 ± 1.26 vs. 43.78 ± 1.62, respectively). The TG level was correlated with betatrophin (r = 0.353, P = 0.013). Multiple regression analysis showed that the AHI, leptin, and arousals were independent predictors of betatrophin level (B = 1.70 P = 0.046 95%, B = 0.56 P < 0.005, and B = 1, 2, P = 0.003, respectively). CONCLUSIONS: Our results suggest a complex relationship between OSA, betatrophin, TG, and HDL, as well as other adipokines. Our results require further investigation to assess this complex association and re-evaluate previous related studies.
format Online
Article
Text
id pubmed-6341867
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-63418672019-02-11 Betatrophin association with serum triglyceride levels in obstructive sleep apnea patients Sertogullarindan, Bunyamin Komuroglu, Ahmet Ufuk Ucler, Rifki Gunbatar, Hulya Sunnetcioglu, Aysel Cokluk, Erdem Ann Thorac Med Original Article BACKGROUND: Obstructive sleep apnea (OSA) is a common sleep problem, in which patients are at increased risk for metabolic and cardiovascular problems, including metabolic syndrome, diabetes mellitus (DM), and dyslipidemia. Betatrophin is a novel protein that regulates fatty acid and triglyceride (TG) metabolism and is related to obesity and metabolic abnormalities, including metabolic syndrome, DM, and dyslipidemia. Although OSA and betatrophin share common abnormalities, their relationship has not been investigated. AIM: The aim of this study is to investigate the relationships among betatrophin, OSA, and the serum lipid profile. METHODS: Ninety consecutive patients with suspected OSA underwent polysomnography (PSG) to confirm OSA. Plasma betatrophin, leptin, adiponectin, and the full lipid profile were analyzed. The patients were categorized as OSA or control based on the apnea-hypopnea index (AHI). RESULTS: About 61% of patients had OSA, and 39% had normal PSG. The levels of betatrophin, leptin, and adiponectin were higher in patients with OSA (256.59 ± 29.35, 374.20 ± 37.93, and 17.86 ± 2.63 μg/mL, respectively) compared to the controls (141.86 ± 26.20, 205.53 ± 14.75, and 7.52 ± 1.02 μg/mL, respectively). Betatrophin levels were correlated with the AHI, leptin (r = 0.413, P = 0.002, r = 0.782, P = 0.000). TG levels were significantly higher, and high-density lipoprotein cholesterol (HDL-C) levels were lower, in OSA patients compared to controls (244 ± 20.33 vs. 138 ± 14.89, and 37.21 ± 1.26 vs. 43.78 ± 1.62, respectively). The TG level was correlated with betatrophin (r = 0.353, P = 0.013). Multiple regression analysis showed that the AHI, leptin, and arousals were independent predictors of betatrophin level (B = 1.70 P = 0.046 95%, B = 0.56 P < 0.005, and B = 1, 2, P = 0.003, respectively). CONCLUSIONS: Our results suggest a complex relationship between OSA, betatrophin, TG, and HDL, as well as other adipokines. Our results require further investigation to assess this complex association and re-evaluate previous related studies. Medknow Publications & Media Pvt Ltd 2019 /pmc/articles/PMC6341867/ /pubmed/30745937 http://dx.doi.org/10.4103/atm.ATM_52_18 Text en Copyright: © 2019 Annals of Thoracic Medicine http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Sertogullarindan, Bunyamin
Komuroglu, Ahmet Ufuk
Ucler, Rifki
Gunbatar, Hulya
Sunnetcioglu, Aysel
Cokluk, Erdem
Betatrophin association with serum triglyceride levels in obstructive sleep apnea patients
title Betatrophin association with serum triglyceride levels in obstructive sleep apnea patients
title_full Betatrophin association with serum triglyceride levels in obstructive sleep apnea patients
title_fullStr Betatrophin association with serum triglyceride levels in obstructive sleep apnea patients
title_full_unstemmed Betatrophin association with serum triglyceride levels in obstructive sleep apnea patients
title_short Betatrophin association with serum triglyceride levels in obstructive sleep apnea patients
title_sort betatrophin association with serum triglyceride levels in obstructive sleep apnea patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341867/
https://www.ncbi.nlm.nih.gov/pubmed/30745937
http://dx.doi.org/10.4103/atm.ATM_52_18
work_keys_str_mv AT sertogullarindanbunyamin betatrophinassociationwithserumtriglyceridelevelsinobstructivesleepapneapatients
AT komurogluahmetufuk betatrophinassociationwithserumtriglyceridelevelsinobstructivesleepapneapatients
AT uclerrifki betatrophinassociationwithserumtriglyceridelevelsinobstructivesleepapneapatients
AT gunbatarhulya betatrophinassociationwithserumtriglyceridelevelsinobstructivesleepapneapatients
AT sunnetciogluaysel betatrophinassociationwithserumtriglyceridelevelsinobstructivesleepapneapatients
AT coklukerdem betatrophinassociationwithserumtriglyceridelevelsinobstructivesleepapneapatients